Skip Navigation

Vaccine Safety Bibliography-July 2014

1. Those most likely to contract shingles are excluded from NHS vaccination programme. Nurs Stand. 2014 Jun 4; 28(40):16.

2. Aebischer T. Leishmania spp. Proteome Data Sets: A Comprehensive Resource for  Vaccine Development to Target Visceral Leishmaniasis. Front Immunol. 2014 Jun 10; 5:260.

3. Al Awaidy ST, Gebremeskel BG, Al Obeidani I, Al Baqlani S, Haddadin W, O Brien MA. Cost effectiveness of a pentavalent rotavirus vaccine in Oman. BMC Infect Dis. 2014 Jun 17; 14(1):334. [Epub ahead of print].

4. Albuquerque LP, Pontual EV, Santana GM, Silva LR, Aguiar JD, Coelho LC, Rêgo MJ, Pitta MG, Silva TG, Melo AM, Napoleão TH, Paiva PM. Toxic effects of Microgramma vacciniifolia rhizome lectin on Artemia salina, human cells, and the  schistosomiasis vector Biomphalaria glabrata. Acta Trop. 2014 Jun 19. [Epub ahead of print].

5. Ali SA, Kazi AM, Cortese MM, Fleming JA, Parashar UD, Jiang B, McNeal MM, Steele D, Bhutta Z, Zaidi A. Impact of Different Dosing Schedules on the Immunogenicity of the Human Rotavirus Vaccine in Infants in Pakistan - a Randomized Trial. J Infect Dis. 2014 Jun 16. [Epub ahead of print].

6. Alves RP, Yang MJ, Batista MT, Ferreira LC. Alzheimer's disease: is a vaccine  possible? Braz J Med Biol Res. 2014 Jun; 47(6):438-44.

7. Andersen P, Kaufmann SH. Novel Vaccination Strategies against Tuberculosis. Cold Spring Harb Perspect Med. 2014 Jun 2; 4(6).

8. Anderson EJ. Time to Begin a New Chapter and Expand Rotavirus Immunization. Clin Infect Dis. 2014 Jun 18. [Epub ahead of print].

9. Andrade AL, Ternes YM, Vieira MA, Moreira WG, Lamaro-Cardoso J, Kipnis A, Cardoso MR, Brandileone MC, Moura I, Pimenta FC, da Gloria Carvalho M, Saraiva FO, Toscano CM, Minamisava R. Direct effect of 10-valent conjugate pneumococcal vaccination on pneumococcal carriage in children Brazil. PLoS One. 2014 Jun 3; 9(6):e98128.

10. Aspinall R, Lang PO. Vaccine responsiveness in the elderly: best practice for the clinic. Expert Rev Vaccines. 2014 Jul; 13(7):885-94.

11. Awali RA, Samuel PS, Marwaha B, Ahmad N, Gupta P, Kumar V, Ellsworth J, Flanagan E, Upfal M, Russell J, Kaplan C, Kaye KS, Chopra T. Understanding health care personnel's attitudes toward mandatory influenza vaccination. Am J Infect Control. 2014 Jun; 42(6):649-52.

12. Baker P. Going gender-neutral with the HPV vaccine. Br J Nurs. 2014 Jun 12;23(11):550-Unknown.

13. Bansal V, Kumar M, Dalela M, Brahmne HG, Singh H. Evaluation of synergistic effect of biodegradable polymeric nanoparticles and aluminum based adjuvant for improving vaccine efficacy. Int J Pharm. 2014 Aug 25;471(1-2):377-84.

14. Barbaro B, Brotherton JM. Assessing HPV vaccine coverage in Australia by geography and socioeconomic status: are we protecting those most at risk? Aust N  Z J Public Health. 2014 Jun 24. [Epub ahead of print].

15. Barhate GA, Gaikwad SM, Jadhav SS, Pokharkar VB. Structure function attributes of gold nanoparticle vaccine association: Effect of particle size and  association temperature. Int J Pharm. 2014 Aug 25;471(1 2):439-48.

16. Barkoff AM, Guiso N, Guillot S, Xing D, Markey K, Berbers G, Mertsola J, He Q. A rapid ELISA-based method for screening Bordetella pertussis strain production of antigens included in current acellular pertussis vaccines. J Immunol Methods. 2014 Jun 10. [Epub ahead of print].

17. Barlow RS, Reynolds LE, Cieslak PR, Sullivan AD. Vaccinated children and adolescents with pertussis infections experience reduced illness severity and duration, Oregon, 2010-2012. Clin Infect Dis. 2014 Jun;58(11):1523-9.

18. Baxter R, Reisinger K, Block SL, Percell S, Odrljin T, Dull PM, Smolenov I. Antibody Persistence after Primary and Booster Doses of a Quadrivalent Meningococcal Conjugate Vaccine in Adolescents. Pediatr Infect Dis J. 2014 Jun 6. [Epub ahead of print].

19. Baxter R, Reisinger K, Block SL, Izu A, Odrljin T, Dull P. Antibody persistence and booster response of a quadrivalent meningococcal conjugate vaccine in adolescents. J Pediatr. 2014 Jun;164(6):1409-1415.e4.

20. Becker-Dreps S, Amaya E, Liu L, Moreno G, Rocha J, Briceño R, Alemán J, Hudgens MG, Woods CW, Weber DJ. Changes in childhood pneumonia and infant mortality rates following introduction of the 13 valent pneumococcal conjugate vaccine in Nicaragua. Pediatr Infect Dis J. 2014 Jun;33(6):637-42.

21. Belongia EA, Sundaram ME, McClure DL, Meece JK, Ferdinands J, VanWormer JJ. Waning vaccine protection against influenza A (H3N2) illness in children and older adults during a single season. Vaccine. 2014 Jun 21. [Epub ahead of print]. 

22. Ben-Shimol S, Greenberg D, Givon-Lavi N, Schlesinger Y, Somekh E, Aviner S, Miron D, Dagan R. Early impact of sequential introduction of 7-valent and 13-valent pneumococcal conjugate vaccine on IPD in Israeli children <5 years: an  active prospective nationwide surveillance. Vaccine. 2014 Jun 5;32(27):3452-9.

23. Beran J, Xie F, Zent O. Five year follow-up after a first booster vaccination against tick-borne encephalitis following different primary vaccination schedules demonstrates long-term antibody persistence and safety. Vaccine. 2014 Jun 17. [Epub ahead of print].

24. Berhane Y, Worku A, Demissie M, Tesfaye N, Asefa N, Aniemaw W, Weldearegawi B, Kebede Y, Shiferaw T, Worku A, Olijira L, Merdekios B, Ashebir Y, Tadesse T, Dessie Y, Meseret S, Ayele G. Children Who Received PCV-10 Vaccine from a Two-Dose Vial without Preservative Are Not More Likely to Develop Injection Site  Abscess Compared with Those Who Received Pentavalent (DPT-HepB-Hib) Vaccine: A Longitudinal Multi-Site Study. PLoS One. 2014 Jun 4; 9(6):e97376.

25. Betsch C, Wicker S. Personal attitudes and misconceptions, not official recommendations guide occupational physicians' vaccination decisions. Vaccine. 2014 Jun 21. [Epub ahead of print].

26. Bhandari N, Rongsen-Chandola T, Bavdekar A, John J, Antony K, Taneja S, Goyal N, Kawade A, Kang G, Rathore SS, Juvekar S, Muliyil J, Arya A, Shaikh H, Abraham  V, Vrati S, Proschan M, Kohberger R, Thiry G, Glass R, Greenberg HB, Curlin G, Mohan K, Harshavardhan GV, Prasad S, Rao TS, Boslego J, Bhan MK; India Rotavirus  Vaccine Group. Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in  Indian infants: a randomised, double-blind, placebo-controlled trial. Lancet. 2014 Jun 21;383(9935):2136-43.

27. Bidzhieva B, Laassri M, Chumakov K. Allele-specific PCR for quantitative analysis of mutants in live viral vaccines. J Virol Methods. 2014 Jun;201:86-92. 

28. Birebent J, Dupouy J, Lempégnat J, Bourrel R, Bismuth M, Oustric S. [Did the  recommendation of the French public health council modify the antipapillomavirus  vaccines' prescription level?]. Rev Epidemiol Sante Publique. 2014 Jun; 62(3):195-9.

29. Block L, Pitts S, Perl TM. Barriers and facilitators of implementation of a mandate for influenza vaccination among healthcare personnel. Infect Control Hosp Epidemiol. 2014 Jun; 35(6):724-7.

30. Bonduelle O, Carrat F, Luyt CE, Leport C, Mosnier A, Benhabiles N, Krivine A, Rozenberg F, Yahia N, Samri A, Rousset D, van der Werf S, Autran B, Combadiere B. Characterization of pandemic influenza immune memory signature after vaccination  or infection. J Clin Invest. 2014 Jun 9. [Epub ahead of print].

31. Boraschi D, Italiani P. Immunosenescence and vaccine failure in the elderly:  Strategies for improving response. Immunol Lett. 2014 Jun 21. [Epub ahead of print].

32. Bravo L, Chitraka A, Liu A, Choudhury J, Kumar K, Berezo LR, Cimafranca LR, Chatterjee P, Garg P, Siriwardene P, Bernardo R, Mehta S, Balasubramanian S, Karkada N, Htay Han H. Reactogenicity and safety of the human rotavirus vaccine,  RotarixTM in The Philippines, Sri Lanka, and India: A post marketing surveillance  study. Hum Vaccin Immunother. 2014 Jun 5; 10(8). [Epub ahead of print].

33. Burger AE, Reither EN. Monitoring receipt of seasonal influenza vaccines with BRFSS and NHIS data: Challenges and solutions. Vaccine. 2014 Jun 30; 32(31):3950-4.

34. Bödeker B, Walter D, Reiter S, Wichmann O. Cross-sectional study on factors associated with influenza vaccine uptake and pertussis vaccination status among pregnant women in Germany. Vaccine. 2014 Jun 10. [Epub ahead of print].

35. Campfield B, Chen K, Kolls JK. Vaccine approaches for multidrug resistant Gram negative infections. Curr Opin Immunol. 2014 Jun; 28C:84-89.

36. Cates JR, Diehl SJ, Crandell JL, Coyne-Beasley T. Intervention effects from a social marketing campaign to promote HPV vaccination in preteen boys. Vaccine. 2014 Jun 2. [Epub ahead of print].

37. Caubet JC, Rudzeviciene O, Gomes E, Terreehorst I, Brockow K, Eigenmann PA. Managing a child with possible allergy to vaccine. Pediatr Allergy Immunol. 2014  Jun;25(4):394-403.

38. Chan TC, Hung IF, Chan KH, Li CP, Li PT, Luk JK, Chu LW, Chan FH. Immunogenicity and Safety of Intradermal Trivalent Influenza Vaccination in Nursing Home Older Adults: A Randomized Controlled Trial. J Am Med Dir Assoc. 2014 Jun 21.

39. Chan TC, Fu YC, Wang DW, Chuang JH. Determinants of Receiving the Pandemic (H1N1) 2009 Vaccine and Intention to Receive the Seasonal Influenza Vaccine in Taiwan. PLoS One. 2014 Jun 27; 9(6):e101083.

40. Childress BC, Montney JD, Albro EA. Making evidence-based selections of influenza vaccines. Hum Vaccin Immunother. 2014 Jun 18;10(9). [Epub ahead of print].

41. Chisti MJ, Salam MA, Ahmed T, Shahid AS, Shahunja KM, Faruque AS, Bardhan PK, Hossain MI, Islam MM, DAS SK, Huq S, Shahrin L, Huq E, Chowdhury F, Ashraf H. Lack of BCG vaccination and other risk factors for bacteraemia in severely malnourished children with pneumonia. Epidemiol Infect. 2014 Jun 3:1-5. [Epub ahead of print].

42. Clark A, Jit M, Andrews N, Atchison C, Edmunds WJ, Sanderson C. Evaluating the potential risks and benefits of infant rotavirus vaccination in England. Vaccine. 2014 Jun 17; 32(29):3604-10.

43. Colvard MD, Hirst JL, Vesper BJ, DeTella GE, Tsagalis MP, Roberg MJ, Peters DE, Wallace JD, James JJ. Just-in-Time Training of Dental Responders in a Simulated Pandemic Immunization Response Exercise. Disaster Med Public Health Prep. 2014 Jun 5:1-5. [Epub ahead of print].

44. Cremers AJ, Meis JF, Walraven G, Jongh CE, Ferwerda G, Hermans PW. Effects of 7-valent pneumococcal conjugate 1 vaccine on the severity of adult 2 bacteremic pneumococcal pneumonia. Vaccine. 2014 Jun 30; 32(31):3989-94.

45. Croucher NJ, Chewapreecha C, Hanage WP, Harris SR, McGee L, van der Linden M, Song JH, Ko KS, de Lencastre H, Turner C, Yang F, Sá-Leão R, Beall B, Klugman KP, Parkhill J, Turner P, Bentley SD. Evidence for soft selective sweeps in the evolution of pneumococcal multidrug-resistance and vaccine escape. Genome Biol Evol. 2014 Jun 10. [Epub ahead of print].

46. Cruze AR, Zhang G, Thomas L, Alonso J, Sandoval L. Frequency and erroneous usage of temporary medical exemptions and knowledge of immunization guidelines among some Miami-Dade County Florida providers. Vaccine. 2014 Jun 20. [Epub ahead of print].

47. Cui Y, Yang X, Xiao X, Anisimov AP, Li D, Yan Y, Zhou D, Rajerison M, Carniel E, Achtman M, Yang R, Song Y. Genetic variations of live attenuated plague vaccine strains (Yersinia pestis EV76 lineage) during laboratory passages in different countries. Infect Genet Evol. 2014 Jun 4;26C:172-179. [Epub ahead of print].

48. da Silva Soares L, de Fátima Dos Santos Guerra S, do Socorro Lima de Oliveira A, da Silva Dos Santos F, de Fátima Costa de Menezes EM, Mascarenhas Jd, Linhares AC. Diversity of rotavirus strains circulating in Northern Brazil after introduction of a rotavirus vaccine: high prevalence of G3P[6] genotype. J Med Virol. 2014 Jun;86(6):1065-72.

49. De Gregorio E, Rappuoli R. From empiricism to rational design: a personal perspective of the evolution of vaccine development. Nat Rev Immunol. 2014 Jul; 14(7):505-14.

50. de Medeiros DM, Silva C, Bueno C, Ribeiro AM, Viana VD, Carvalho JF, Bonfa E. Pandemic influenza immunization in primary antiphospholipid syndrome (PAPS): a trigger to thrombosis and autoantibody production? Lupus. 2014 Jun 24. [Epub ahead of print].

51. Deering RP, Kommareddy S, Ulmer JB, Brito LA, Geall AJ. Nucleic acid vaccines: prospects for non-viral delivery of mRNA vaccines. Expert Opin Drug Deliv. 2014 Jun; 11(6):885-99.

52. Dempsey AF, Fuhrel-Forbis A, Konrath S. Use of the Carolina HPV Immunization  Attitudes and Beliefs Scale (CHIAS) in Young Adult Women. PLoS One. 2014 Jun 19; 9(6):e100193.

53. Doherty E, Walsh B, O'Neill C. Decomposing socioeconomic inequality in child  vaccination: results from Ireland. Vaccine. 2014 Jun 5;32(27):3438-44.

54. Domingues CM, Verani JR, Montenegro Renoiner EI, de Cunto Brandileone MC, Flannery B, de Oliveira LH, Santos JB, de Moraes JC; Brazilian Pneumococcal Conjugate Vaccine Effectiveness Study Group. Effectiveness of ten-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazil: a matched case-control study. Lancet Respir Med. 2014 Jun; 2(6):464-71.

55. Dominicus R, Galtier F, Richard P, Baudin M. Immunogenicity and safety of one dose of diphtheria, tetanus, acellular pertussis and poliomyelitis vaccine (Repevax(®)) followed by two doses of diphtheria, tetanus and poliomyelitis vaccine (Revaxis(®)) in adults aged ≥40 years not receiving a diphtheria- and tetanus-containing vaccination in the last 20 years. Vaccine. 2014 Jun 30;32(31):3942-9.

56. Donahue KL, Stupiansky NW, Alexander AB, Zimet GD. Acceptability of the human papillomavirus vaccine and reasons for non-vaccination among parents of adolescent sons. Vaccine. 2014 Jun 30; 32(31):3883-5.

57. Durán-Lobato M, Carrillo-Conde BR, Khairandish Y, Peppas NA. Surface-modified P(HEMA-co-MAA) Nanogel Carriers for Oral Vaccine Delivery: Design, Characterization, and In Vitro Targeting Evaluation. Biomacromolecules. 2014 Jun  23. [Epub ahead of print].

58: Díaz-Ortega JL, Bennett JV, Castañeda-Desales D, Quintanilla DM, Martínez D,  Castro JF. Booster immune response in children 6-7 years of age, randomly assigned to four groups with two MMR vaccines applied by aerosol or by injection. Vaccine. 2014 Jun 17; 32(29):3680-6.

59. Elkin ZP, Cohen EJ, Goldberg JD, Li X, Castano E, Gillespie C, Haberman I, Jung JJ, Zabar S, Park L, Perskin MH. Improving Adherence to National Recommendations for Zoster Vaccination Through Simple Interventions. Eye Contact  Lens. 2014 Jun 4. [Epub ahead of print].

60. Ely GE, Fields M, Dignan M. School-Based Vaccination Programs and the HPV Vaccine in 16 Appalachian Kentucky School Districts: Results from a Pilot Study.  Soc Work Public Health. 2014 Jun 7;29(4):368-79.

61. Epperson S, Blanton L, Kniss K, Mustaquim D, Steffens C, Wallis T, Dhara R, Leon M, Perez A, Chaves SS, Elal AA, Gubareva L, Xu X, Villanueva J, Bresee J, Cox N, Finelli L, Brammer L; Influenza Division, National Center for Immunization and Respiratory Diseases, CDC. Influenza activity - United States, 2013-14 season and composition of the 2014-15 influenza vaccines. MMWR Morb Mortal Wkly Rep. 2014 Jun 6;63(22):483-90.

62. Ercoli L, Iacovone G, De Luca S, Mancinelli S, Gilardi F, Boscherini B, Palombi L, Buonomo E. Unequal access, low vaccination coverage, growth retardation rates among immigrants children in Italy are exacerbated in Roma immigrants. Minerva Pediatr. 2014 Jun 19. [Epub ahead of print].

63. Eric Feinstein H, Tifrea D, Sun G, Popot JL, de la Maza LM, Cocco MJ. Long-Term Stability of a Vaccine Formulated with the Amphipol-Trapped Major Outer Membrane Protein from Chlamydia trachomatis. J Membr Biol. 2014 Jun 19. [Epub ahead of print].

64. Esposito S, Mastrolia MV, Ghio L, Paglialonga F, Terranova L, Scala A, Edefonti A, Principi N. Influenza immunization in hemodialyzed or kidney transplanted adolescents and young adults. Expert Rev Vaccines. 2014 Jun 27:1-8.  [Epub ahead of print].

65. Fateh M, Emamian MH, Zahraei SM, Fotouhi A. Syringe-type and Needle Gauge Have no Role in Adverse Events Following DTwP Immunization: A Randomized Multicenter Trial. Pediatr Infect Dis J. 2014 Jun 5. [Epub ahead of print].

66. Feldman C, Anderson R. Review: Current and new generation pneumococcal vaccines. J Infect. 2014 Jun 23. [Epub ahead of print].

67. Fernandes EG, Sato HK, Leshem E, Flannery B, Konstantyner TC, Veras MA, Patel MM. Impact of rotavirus vaccination on diarrhea-related hospitalizations in São Paulo State, Brazil. Vaccine. 2014 Jun 5; 32(27):3402-8.

68. Feroldi E, Pancharoen C, Kosalaraksa P, Chokephaibulkit K, Boaz M, Meric C, Hutagalung Y, Bouckenooghe A. Primary immunization of infants and toddlers in Thailand with Japanese encephalitis chimeric virus vaccine in comparison with SA14-14-2: a randomized study of immunogenicity and safety. Pediatr Infect Dis J. 2014 Jun;33(6):643-9.

69. Fleckenstein JM, Sheikh A. Designing Vaccines to Neutralize Effective Toxin Delivery by Enterotoxigenic Escherichia coli. Toxins (Basel). 2014 Jun 10; 6(6):1799-812.

70. Fosco M, Gualdrini G, Ben Ayad R. The role of active immunization therapy as  preoperative treatment for chronic osteomyelitis. Musculoskelet Surg. 2014 Jun; 98(1):45-52.

71. Gaglani M, Spencer S, Ball S, Song J, Naleway A, Henkle E, Bozeman S, Reynolds S, Sessions W, Hancock K, Thompson M. Antibody response to influenza A(H1N1)pdm09 among healthcare personnel receiving trivalent inactivated vaccine:  effect of prior monovalent inactivated vaccine. J Infect Dis. 2014 Jun 1;209(11):1705-14.

72. Garg NK, Dwivedi P, Jain A, Tyagi S, Sahu T, Tyagi RK. Development of novel carrier(s) mediated tuberculosis vaccine: More than a tour de force. Eur J Pharm  Sci. 2014 Jun 5;62C:227-242. [Epub ahead of print].

73. Ghosh S, Prava J, Samal HB, Suar M, Mahapatra RK. Comparative genomics study  for the identification of drug and vaccine targets in Staphylococcus aureus: MurA ligase enzyme as a proposed candidate. J Microbiol Methods. 2014 Jun; 101:1-8.

74. Greenberg DP, Robertson CA, Landolfi VA, Bhaumik A, Senders SD, Decker MD. Safety and immunogenicity of an inactivated quadrivalent influenza vaccine in children 6 months through 8 years of age. Pediatr Infect Dis J. 2014 Jun; 33(6):630-6.

75. Griffin DE. Current progress in pulmonary delivery of measles vaccine. Expert Rev Vaccines. 2014 Jun;13(6):751-9.

76. Griffiths KL, Khader SA. Novel vaccine approaches for protection against intracellular pathogens. Curr Opin Immunol. 2014 Jun; 28C:58-63.

77. Grimaldi-Bensouda L, Le Guern V, Kone-Paut I, Aubrun E, Fain O, Ruel M, Machet L, Viallard JF, Magy-Bertrand N, Daugas E, Rossignol M, Abenhaim L, Costedoat-Chalumeau N; PGRx Lupus Study Group. The risk of systemic lupus erythematosus associated with vaccines: an international case-control study. Arthritis Rheumatol. 2014 Jun; 66(6):1559-67.

78. Gudlavalleti SK, Crawford EN, Harder JD, Reddy JR. Quantification of each Serogroup Polysaccharide of Neisseria meningitidis in A/C/Y/W-135-DT Conjugate Vaccine by High-Performance Anion-Exchange Chromatography-Pulsed Amperometric Detection Analysis. Anal Chem. 2014 Jun 3; 86(11):5383-90.

79. Guignard AP, Greenberg M, Lu C, Rosillon D, Vannappagari V. Risk of herpes zoster among diabetics: a matched cohort study in a US insurance claim database before introduction of vaccination, 1997-2006. Infection. 2014 Jun 29. [Epub ahead of print].

80. Guthmann JP, Chauvin P, Le Strat Y, Soler M, Fonteneau L, Lévy-Bruhl D. [Low  pneumococcal conjugated vaccine immunization coverage in low-income families: A study in Île-de-France]. Arch Pediatr. 2014 Jun; 21(6):584-92.

81. Hall GC, Hill F. Descriptive investigation of the recording of influenza vaccination details on The Health Information Network database. Pharmacoepidemiol Drug Saf. 2014 Jun; 23(6):595-600.

82. Hambidge SJ, Newcomer SR, Narwaney KJ, Glanz JM, Daley MF, Xu S, Shoup JA, Rowhani-Rahbar A, P Klein N, Lee GM, Nelson JC, Lugg M, Naleway AL, Nordin JD, Weintraub E, DeStefano F. Timely versus delayed early childhood vaccination and seizures. Pediatrics. 2014 Jun; 133(6):e1492-9.

83. Hamidi A, Boog C, Jadhav S, Kreeftenberg H. Lessons learned during the development and transfer of technology related to a new Hib conjugate vaccine to  emerging vaccine manufacturers. Vaccine. 2014 Jun 9. [Epub ahead of print].

84. Haralambieva IH, Lambert ND, Ovsyannikova IG, Kennedy RB, Larrabee BR, Pankratz VS, Poland GA. Associations between Single Nucleotide Polymorphisms in Cellular Viral Receptors and Attachment Factor-Related Genes and Humoral Immunity to Rubella Vaccination. PLoS One. 2014 Jun 19; 9(6):e99997.

85. Harder M, Christensson K, Söderbäck M. Undergoing an immunization is effortlessly, manageable or difficult according to five-year-old children. Scand  J Caring Sci. 2014 Jun 30. [Epub ahead of print].

86. Hasan H, Deris ZZ, Sulaiman SA, Abdul Wahab MS, Naing NN, Ab Rahman Z, Othman NH. Effect of Influenza Vaccination on Acute Respiratory Symptoms in Malaysian Hajj Pilgrims. J Immigr Minor Health. 2014 Jun 20. [Epub ahead of print].

87. He H, Chen E, Chen H, Wang Z, Li Q, Yan R, Guo J, Zhou Y, Pan J, Xie S. Similar immunogenicity of measles-mumps-rubella (MMR) vaccine administrated at 8  months versus 12 months age in children. Vaccine. 2014 Jun 30; 32(31):4001-5.

88. Hedden MA, Kuehl PG, Liu Y. Economic analysis of a herpes zoster vaccination  program in 19 affiliated supermarket pharmacies. J Am Pharm Assoc (2003). 2014 Jun 22:e281-e287. [Epub ahead of print].

89. Hegerle N, Guiso N. Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines. Expert Rev Vaccines. 2014 Jun 23:1-12.  [Epub ahead of print].

90. Hemming M, Vesikari T. Detection of rotateq vaccine-derived, double-reassortant rotavirus in a 7-year-old child with acute gastroenteritis. Pediatr Infect Dis J. 2014 Jun; 33(6):655-6.

91. Hofstetter AM, Rosenthal SL. Factors impacting HPV vaccination: lessons for health care professionals. Expert Rev Vaccines. 2014 Jun 26:1-14. [Epub ahead of print].

92. Hortal M, Estevan M, Meny M, Iraola I, Laurani H. Impact of pneumococcal conjugate vaccines on the incidence of pneumonia in hospitalized children after five years of its introduction in uruguay. PLoS One. 2014 Jun 6;9(6):e98567.

93. Hoshi SL, Kondo M, Okubo I. Economic evaluation of vaccination programme of mumps vaccine to the birth cohort in Japan. Vaccine. 2014 Jun 9. [Epub ahead of print].

94. Hotez PJ, Bottazzi ME, Tseng CT, Zhan B, Lustigman S, Du L, Jiang S. Calling for rapid development of a safe and effective MERS vaccine. Microbes Infect. 2014 Jun 12. [Epub ahead of print].

95. Hou Z, JieChang, Yue D, Fang H, Meng Q, Zhang Y. Determinants of willingness to pay for self-paid vaccines in China. Vaccine. 2014 Jun 23. [Epub ahead of print].

96. Hočevar-Boltełar I, Matičič M, Sereg-Bahar M, Gale N, Poljak M, Kocjan B, Zargi M. Human papilloma virus vaccination in patients with an aggressive course of recurrent respiratory papillomatosis. Eur Arch Otorhinolaryngol. 2014 Jun 26.  [Epub ahead of print].

97. Hu D, Yang X, Wu J, Wang G, Wang W, Qi Z, Chen G, Zhang R. [Preparation of an autophagy-targeted antituberculosis DNA vaccine encoding LpqH fused with LC3]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2014 Jun; 30(6):581-4. Chinese.  

98. Hurtaud A, Songis PH, Di Patrizio P, Boivin JM. [Impact of the A influenza pandemic on anti-seasonal influenza vaccination of French general practitioners:  A cohort follow-up 2007-2010]. Rev Epidemiol Sante Publique. 2014 Jun; 62(3):191-4.

99. Ilyina N, Kharit S, Namazova-Baranova L, Asatryan A, Benashvili M, Tkhostova E, Bhusal C, Arora AK. Safety and immunogenicity of meningococcal ACWY CRM (197)-conjugate vaccine in children, adolescents, and adults in Russia. Hum Vaccin Immunother. 2014 Jun 20; 10(8). [Epub ahead of print].

100. Imöhl M, van der Linden M. [Invasive pneumococcal disease in Germany in the  era of pneumococcal conjugate vaccination]. Dtsch Med Wochenschr. 2014 Jun; 139(25-26):1346-51.

101. Izadi S, Shahmahmoodi S, Zahraei SM, Dorostkar F, Majdzadeh R. Risk of polio reintroduction to border regions of Islamic Republic of Iran: seroprevalence study of children with at least 5 doses of oral polio vaccine. East Mediterr Health J. 2014 Jun 9; 20(5):287-94.

102. Jahnmatz M, Amu S, Ljungman M, Wehlin L, Chiodi F, Mielcarek N, Locht C, Thorstensson R. B-cell responses after intranasal vaccination with the novel attenuated Bordetella pertussis vaccine strain BPZE1 in a randomized phase I clinical trial. Vaccine. 2014 Jun 5; 32(27):3350-6.

103. Jakka P, Reddy YK, Kirubaharan JJ, Chandran ND. Evaluation of immune responses by live infectious bursal disease vaccines to avoid vaccination failures. Eur J Microbiol Immunol (Bp). 2014 Jun; 4(2):123-7.

104. Jiménez-García R, Hernandez-Barrera V, Rodríguez-Rieiro C, Carrasco Garrido  P, López de Andres A, Jimenez-Trujillo I, Esteban-Vasallo MD, Domínguez-Berjón MF, de Miguel-Diez J, Astray-Mochales J. Comparison of self-report influenza vaccination coverage with data from a population based computerized vaccination registry and factors associated with discordance. Vaccine. 2014 Jun 23. [Epub ahead of print].

105. Jin H, Chen Z. Production of live attenuated influenza vaccines against seasonal and potential pandemic influenza viruses. Curr Opin Virol. 2014 Jun; 6C:34-39.

106. Kaaijk P, Kleijne DE, Knol MJ, Harmsen IA, Ophorst OJ, Rots NY. Parents' attitude toward multiple vaccinations at a single visit with alternative delivery methods. Hum Vaccin Immunother. 2014 Jun 23;10(8). [Epub ahead of print].

107. Kaddar M, Milstien J, Schmitt S. Impact of BRICS' investment in vaccine development on the global vaccine market. Bull World Health Organ. 2014 Jun 1; 92(6):436-46.

108. Kao CM, Schneyer RJ, Bocchini JA Jr. Child and adolescent immunizations: selected review of recent US recommendations and literature. Curr Opin Pediatr. 2014 Jun; 26(3):383-95.

109. Kaufman M, Pardo G, Rossman H, Sweetser MT, Forrestal F, Duda P. Natalizumab treatment shows no clinically meaningful effects on immunization responses in patients with relapsing-remitting multiple sclerosis. J Neurol Sci. 2014 Jun 15;341(1-2):22-7.

110. Kelso JM. Administering influenza vaccine to egg-allergic persons. Expert Rev Vaccines. 2014 Jun 25:1-9. [Epub ahead of print].

111. Kester KE, Gray Heppner D Jr, Moris P, Ofori-Anyinam O, Krzych U, Tornieporth N, McKinney D, Delchambre M, Ockenhouse CF, Voss G, Holland C, Beckey JP, Ballou WR, Cohen J; the RTS,S/TRAP Group. Sequential Phase 1 and Phase 2 randomized, controlled trials of the safety, immunogenicity and efficacy of combined pre-erythrocytic vaccine antigens RTS,S and TRAP formulated with AS02 Adjuvant System in healthy, malaria naïve adults. Vaccine. 2014 Jun 17. [Epub ahead of print].

112. Kharbanda EO, Vazquez-Benitez G, Lipkind H, Naleway AL, Klein NP, Cheetham TC, Hambidge SJ, Vellozzi C, Nordin JD. Receipt of pertussis vaccine during pregnancy across 7 Vaccine Safety Datalink Sites. Prev Med. 2014 Jun 18. [Epub ahead of print].

113. Knuf M, Leroux-Roels G, Rümke HC, Abarca K, Rivera L, Lattanzi M, Pedotti P, Arora A, Kieninger-Baum D, Cioppa GD. Immunogenicity and Tolerability of an MF59®-Adjuvanted, Egg-Derived, A/H1N1 Pandemic Influenza Vaccine in Children 6-35 Months of Age. Pediatr Infect Dis J. 2014 Jun 20. [Epub ahead of print].

114. Koepke R, Eickhoff JC, Ayele RA, Petit AB, Schauer SL, Hopfensperger DJ, Conway JH, Davis JP. Estimating the Effectiveness of Tdap Vaccine for Preventing  Pertussis: Evidence of Rapidly Waning Immunity and Differences in Effectiveness by Tdap Brand. J Infect Dis. 2014 Jun 5. [Epub ahead of print].

115. Kraan H, Vrieling H, Czerkinsky C, Jiskoot W, Kersten G, Amorij JP. Buccal and sublingual vaccine delivery. J Control Release. 2014 Jun 6. [Epub ahead of print].

116. Krause S, Landherr U, Agardh CD, Hausmann S, Link K, Hansen JM, Lynch KF, Powell M, Furmaniak J, Rees-Smith B, Bonifacio E, Ziegler AG, Lernmark A, Achenbach P. GAD autoantibody affinity in adult patients with latent autoimmune diabetes, the study participants of a GAD65 vaccination trial. Diabetes Care. 2014 Jun; 37(6):1675-80.

117. Krishnarajah G, Landsman-Blumberg P, Eynullayeva E. Rotavirus vaccination compliance and completion in a Medicaid infant population. Vaccine. 2014 Jun 21.  [Epub ahead of print].

118. Krishnarajah G, Demissie K, Lefebvre P, Gaur S, Sheng Duh M. Clinical and cost burden of rotavirus infection before and after introduction of rotavirus vaccines among commercially and Medicaid insured children in the United States. Hum Vaccin Immunother. 2014 Jun 17;10(8). [Epub ahead of print].

119. Kumar D. Immunizations following solid-organ transplantation. Curr Opin Infect Dis. 2014 Jun 19. [Epub ahead of print].

120. Kung YH, Chiu NC, Lee KS, Chang L, Huang DT, Huang FY, Hsieh YC, Huang LM, Chi H. Bacterial etiology of acute otitis media in the era prior to universal pneumococcal vaccination in Taiwanese children. J Microbiol Immunol Infect. 2014  Jun;47(3):239-44.

121. Lang PO, Aspinall R. Vaccination in the Elderly: What Can Be Recommended? Drugs Aging. 2014 Jun 14. [Epub ahead of print].

122. Lanzieri TM, Bialek SR, Ortega-Sanchez IR, Gambhir M. Modeling the potential impact of vaccination on the epidemiology of congenital cytomegalovirus infection. Vaccine. 2014 Jun 24;32(30):3780-6.

123. Lasset C, Kalecinski J, Régnier V, Barone G, Leocmach Y, Vanhems P, Chauvin  F, Lutringer-Magnin D. Practices and opinions regarding HPV vaccination among French general practitioners: evaluation through two cross-sectional studies in 2007 and 2010. Int J Public Health. 2014 Jun; 59(3):519-28.

124. Launay O, Boelle PY, Krivine A, Grenet D, Boussaud V, Rémus N, Corvol H, Chedevergne F, Hubert D, Sermet-Gaudelus I; Inserm MUCOFLU group. Factors associated with humoral immune response to pandemic A/H1N1(v) 2009 influenza vaccine in cystic fibrosis. Vaccine. 2014 Jun 17. [Epub ahead of print].

125. Lawrence HY, Hausman BL, Dannenberg CJ. Reframing medicine's publics: the local as a public of vaccine refusal. J Med Humanit. 2014 Jun; 35(2):111-29.

126. Lee AS, Berendes DM, Seib K, Whitney EA, Chavez RS, Meyer PL, Berkelman RL,  Omer SB, Spaulding AC. Distribution of A(H1N1)pdm09 Influenza Vaccine: Need for Greater Consideration of Smaller Jails. J Correct Health Care. 2014 Jun 16; 20(3):228-239. [Epub ahead of print].

127. Lefkowitz ES, Kelly KM B S, Vasilenko SA, Maggs JL. Correlates of human papillomavirus vaccination among female university students. Women Health. 2014 Jun 25. [Epub ahead of print].

128. Leshem E, Moritz RE, Curns AT, Zhou F, Tate JE, Lopman BA, Parashar UD. Rotavirus Vaccines and Health Care Utilization for Diarrhea in the United States  (2007-2011). Pediatrics. 2014 Jun 9. [Epub ahead of print].

129. Levin A, Wang SA, Levin C, Tsu V, Hutubessy R. Costs of Introducing and Delivering HPV Vaccines in Low and Lower Middle Income Countries: Inputs for GAVI Policy on Introduction Grant Support to Countries. PLoS One. 2014 Jun 26; 9(6):e101114.

130. Levin Y, Kochba E, Kenney R. Clinical evaluation of a novel microneedle device for intradermal delivery of an influenza vaccine: Are all delivery methods the same? Vaccine. 2014 Jun 13. [Epub ahead of print].

131. Levy C, Varon E, Taha MK, Béchet S, Bonacorsi S, Cohen R, Bingen E. [Change  in French bacterial meningitis in children resulting from vaccination]. Arch Pediatr. 2014 Jul; 21(7):736-44.

132. Li J, Menzies D, Landry JS, Benedetti A, Rousseau MC. Determinants of Bacillus Calmette-Guérin (BCG) vaccination among Québec children. Prev Med. 2014  Jun 16. [Epub ahead of print].

133. Li X, Gao X, Ren Z, Cao Y, Wang J, Liang G. A Spatial and Temporal Analysis  of Japanese Encephalitis in Mainland China, 1963-1975: A Period without Japanese  Encephalitis Vaccination. PLoS One. 2014 Jun 9;9(6):e99183.

134. Lin G, Huang H, Liu T, He C, Liu J, Chen S, Hou J, Ren Z, Dong W, Wu Y. A time-resolved fluoroimmunoassay for the quantitation of rabies virus nucleoprotein in the rabies vaccine. J Virol Methods. 2014 Jun 10; 206C:89-94. [Epub ahead of print].

135. Lindblom P, Wilhelmsson P, Fryland L, Matussek A, Haglund M, Sjöwall J, Vene S, Nyman D, Forsberg P, Lindgren PE. Factors Determining Immunological Response to Vaccination against Tick Borne Encephalitis Virus in Older Individuals. PLoS One. 2014 Jun 26; 9(6):e100860.

136. Livio S, Strockbine N, Panchalingam S, Tennant SM, Barry EM, Marohn ME, Antonio M, Hossain A, Mandomando I, Ochieng JB, Oundo JO, Qureshi S, Ramamurthy T, Tamboura B, Adegbola RA, Hossain MJ, Saha D, Sen S, Faruque AS, Alonso PL, Breiman RF, Zaidi AK, Sur D, Sow SO, Berkeley LY, O'Reilly C, Mintz ED, Biswas K, Cohen D, Farag TH, Nasrin D, Wu Y, Blackwelder WC, Kotloff KL, Nataro JP, Levine  MM. Shigella isolates from the Global Enteric Multicenter Study (GEMS) Inform Vaccine Development. Clin Infect Dis. 2014 Jun 23. [Epub ahead of print].

137. MacDonald SE, Dover DC, Simmonds KA, Svenson LW. Risk of febrile seizures after first dose of measles-mumps-rubella-varicella vaccine: a population-based cohort study. CMAJ. 2014 Jun 9. [Epub ahead of print].

138. MacNeil JR, Rubin L, McNamara L, Briere EC, Clark TA, Cohn AC; Meningitis and Vaccine Preventable Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, CDC. Use of MenACWY-CRM Vaccine in Children Aged 2 Through 23 Months at Increased Risk for Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices, 2013. MMWR Morb Mortal Wkly Rep. 2014 Jun 20; 63(24):527-30.

139. Magalhaes I, Eriksson M, Linde C, Muhammad R, Rane L, Ambati A, Axelsson-Robertson R, Khalaj B, Alvarez-Corrales N, Lapini G, Montomoli E, Linde  A, Pedersen NL, Maeurer M. Difference in immune response in vaccinated and unvaccinated Swedish individuals after the 2009 influenza pandemic. BMC Infect Dis. 2014 Jun 11;14(1):319.

140. Mahon BE, Newton AE, Mintz ED. Effectiveness of typhoid vaccination in US travelers. Vaccine. 2014 Jun 17;32(29):3577-9.

141. Maluquer de Motes C, Schiffner T, Sumner RP, Smith GL. Vaccinia virus virulence factor N1 can be ubiquitylated on multiple lysine residues. J Gen Virol. 2014 Jun 8. [Epub ahead  of print].

142. Marsh K, Chapman R, Baggaley RF, Largeron N, Bresse X. Mind the gaps: What's missing from current economic evaluations of universal HPV vaccination? Vaccine.  2014 Jun 24; 32(30):3732-3739.

143. Martin DW, Lowery NE, Brand B, Gold R, Horlick G. Immunization Information Systems: A Decade of Progress in Law and Policy. J Public Health Manag Pract. 2014 Jun 6. [Epub ahead of print].

144. Martins CL, Benn CS, Andersen A, Balé C, Schaltz-Buchholzer F, Do VA, Rodrigues A, Aaby P, Ravn H, Whittle H, Garly ML. A randomized trial of a standard dose of Edmonston-Zagreb measles vaccine given at 4.5 months of age: effect on total hospital admissions. J Infect Dis. 2014 Jun 1; 209(11):1731-8.

145. Martínez-Diz S, Martínez Romero M, Fernández-Prada M, Cruz Piqueras M, Molina Ruano R, Fernández Sierra MA. [Demands and expectations of parents who refuse vaccinations and perspective of health professional on the refusal to vaccinate]. An Pediatr (Barc). 2014 Jun; 80(6):370-8.

146. Matson DO, Vesikari T, Dennehy P, Dallas MD, Goveia MG, Itzler RF, Ciarlet M. Analysis by rotavirus gene 6 reverse transcriptase-polymerase chain reaction assay of rotavirus-positive gastroenteritis cases observed during the vaccination phase of the Rotavirus Efficacy and Safety Trial (REST). Hum Vaccin Immunother. 2014 Jun 5;10(8). [Epub ahead of print].

147. Maurer J, Harris KM. Issuance of patient reminders for influenza vaccination by US-based primary care physicians during the first year of universal influenza  vaccination recommendations. Am J Public Health. 2014 Jun;104(6):e60-2.

148. Mazurek JM, White GE, Moorman JE, Storey E. Influenza Vaccination Among Persons with Work Related Asthma. Am J Prev Med. 2014 Jun 17. [Epub ahead of print].

149. Mbabazi WB, Tabu CW, Chemirmir C, Kisia J, Ali N, Corkum MG, Bartley GL. Innovations in communication technologies for measles supplemental immunization activities: lessons from Kenya measles vaccination campaign, November 2012. Health Policy Plan. 2014 Jun 11. [Epub ahead of print].

150. McElligott M, Vickers I, Cafferkey M, Cunney R, Humphreys H. Non-invasive pneumococcal serotypes and antimicrobial susceptibilities in a paediatric hospital in the era of conjugate vaccines. Vaccine. 2014 Jun 12;32(28):3495-500.  

151. McNeil MM, Cano M, Miller E, Petersen BW, Engler RJ, Bryant-Genevier MG. Ischemic cardiac events and other adverse events following ACAM2000(®) smallpox vaccine in the vaccine adverse event reporting system. Vaccine. 2014 Jun 18. [Epub ahead of print].

152. Michelsen SW, Soborg B, Koch A, Carstensen L, Hoff ST, Agger EM, Lillebaek T, Sorensen HC, Wohlfahrt J, Melbye M. The effectiveness of BCG vaccination in preventing Mycobacterium tuberculosis infection and disease in Greenland. Thorax. 2014 Jun 26. [Epub ahead of print].

153. Minodier L, Blanchon T, Souty C, Turbelin C, Leccia F, Varesi L, Falchi A. Influenza vaccine effectiveness: best practice and current limitations of the screening method and their implications for the clinic. Expert Rev Vaccines. 2014 Jun 19:1-10. [Epub ahead of print].

154. Mody SK, Nair S, Dasgupta A, Raj A, Donta B, Saggurti N, Naik DD, Silverman  JG. Postpartum contraception utilization among low-income women seeking immunization for infants in Mumbai, India. Contraception. 2014 Jun; 89(6):516-20.  

155. Moniz MH, Beigi RH. Maternal immunization: Clinical experiences, challenges, and opportunities in vaccine acceptance. Hum Vaccin Immunother. 2014 Jun 25; 10(9). [Epub ahead of print].

156. Monk HM, Motsney AJ, Wade KC. Safety of Rotavirus Vaccine in the NICU. Pediatrics. 2014 Jun; 133(6):e1555-60.

157. Moreland NJ, Waddington CS, Williamson DA, Sriskandan S, Smeesters PR, Proft T, Steer AC, Walker MJ, Baker EN, Baker MG, Lennon D, Dunbar R, Carapetis J, Fraser JD. Working towards a Group A Streptococcal vaccine: Report of a collaborative Trans-Tasman workshop. Vaccine. 2014 Jun 24; 32(30):3713-20.

158. Moss JL, Feld AL, O'Malley B, Entzel P, Smith JS, Gilkey MB, Brewer NT. Opportunities for increasing human papillomavirus vaccine provision in school health centers. J Sch Health. 2014 Jun; 84(6):370-8.

159. Mura M, Pfleiderer M, Trouvin JH, Brasseur D, Granstrom M, Shivji R, Cavaleri M. Summary of knowledge gaps related to quality and efficacy of current  influenza vaccines. Vaccine. 2014 Jun 19. [Epub ahead of print].

160. Nahrendorf W, Scholzen A, Bijker EM, Teirlinck AC, Bastiaens GJ, Schats R, Hermsen CC, Visser LG, Langhorne J, Sauerwein RW. Memory B-cell and antibody responses induced by Plasmodium falciparum sporozoite immunization. J Infect Dis. 2014 Jun 25. [Epub ahead of print].

161. Newall AT, Jit M, Hutubessy R. Are current cost-effectiveness thresholds for low- and middle-income countries useful? Examples from the world of vaccines. Pharmacoeconomics. 2014

162. Newcombe J, Kaur R, Wood N, Seale H, Palasanthiran P, Snelling T. Prevalence and determinants of influenza vaccine coverage at tertiary pediatric hospitals. Vaccine. 2014 Jun 21. [Epub ahead of print].

163. Nogales A, Baker SF, Ortiz-Riaño E, Dewhurst S, Topham DJ, Martínez-Sobrido  L. Influenza A virus attenuation by codon deoptimization of the NS gene for vaccine development. J Virol. 2014 Jun 25. [Epub ahead of print].

164. Nolan T, Izurieta P, Lee BW, Chan PC, Marshall H, Booy R, Drame M, Vaughn DW. Heterologous Prime-boost Vaccination Using an H5N1-AS03-adjuvanted Influenza  Vaccine in Infants and Children Under 3 Years of Age. J Infect Dis. 2014 Jun 27. [Epub ahead of print].

165. Nowrouzi-Kia B, McGeer A. External cues to action and influenza vaccination  among post-graduate trainee physicians in Toronto, Canada. Vaccine. 2014 Jun 24; 32(30):3830-4.

166. Ntumngia FB, Barnes SJ, McHenry AM, George MT, Schloegel J, Adams JH. Immunogenicity of a synthetic vaccine based on the Plasmodium vivax Duffy Binding Protein Region II. Clin Vaccine Immunol. 2014 Jun 25. [Epub ahead of print].

167. Nunes B, Machado A, Guiomar R, Pechirra P, Conde P, Cristovão P, Falcão I. Estimates of 2012/13 influenza vaccine effectiveness using the case test-negative control design with different influenza negative control groups. Vaccine. 2014 Jun 21. [Epub ahead of print].

168. O'Connor D, Moore CE, Snape MD, John T, Hill AV, Pollard AJ. Exonic single nucleotide polymorphisms within TLR3 associated with infant responses to serogroup C meningococcal conjugate vaccine. Vaccine. 2014 Jun 5;32(27):3424-30.  

169. O'Grady KA, McHugh L, Nolan T, Richmond P, Wood N, Marshall HS, Lambert SB,  Chatfield M, Andrews RM. FluMum: a prospective cohort study of mother-infant pairs assessing the effectiveness of maternal influenza vaccination in prevention of influenza in early infancy. BMJ Open. 2014 Jun 24; 4(6):e005676.

170. Oleszycka E, Lavelle EC. Immunomodulatory properties of the vaccine adjuvant alum. Curr Opin Immunol. 2014 Jun;28C:1-5.

171. Oprea E, Ruta LL, Nicolau I, Popa CV, Neagoe AD, Farcasanu IC. Vaccinium corymbosum L. (blueberry) extracts exhibit protective action against cadmium toxicity in Saccharomyces cerevisiae cells. Food Chem. 2014 Jun 1; 152:516-21.

172. Ovsyannikova IG, Pankratz VS, Salk HM, Kennedy RB, Poland GA. HLA alleles associated with the adaptive immune response to smallpox vaccine: a replication study. Hum Genet. 2014 Jun 1. [Epub ahead of print].

173. Pacheco J, Boushey G. Public health and agenda setting: determinants of state attention to tobacco and vaccines. J Health Polit Policy Law. 2014 Jun;39(3):565-89.

174. Pagliusi S, Tipoo P, Sivaramakrishnan V, Nguyen T; DCVMN Executive Committee. Better vaccines for healthier life. Part II. Conference report of the  DCVMN International 14th Annual General Meeting Hanoi, Vietnam. Vaccine. 2014 Jun 9. [Epub ahead of print].

175. Partinen M, Kornum BR, Plazzi G, Jennum P, Julkunen I, Vaarala O. Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination. Lancet Neurol. 2014 Jun; 13(6):600-13.

176. Patel M, Pabst L, Chattopadhyay S, Hopkins D, Groom H, Myerburg S, Morgan JM; and the Community Preventive Services Task Force. Economic Review of Immunization Information Systems to Increase Vaccination Rates: A Community Guide Systematic Review. J Public Health Manag Pract. 2014 Jun 6. [Epub ahead of print].

177. Patel M, Romero-Steiner S, Broderick MP, Thomas CG, Plikaytis BD, Schmidt DS, Johnson SE, Milton AS, Carlone GM, Clark TA, Messonnier NE, Cohn AC, Faix DJ. Persistence of serogroup C antibody responses following quadrivalent meningococcal conjugate vaccination in United States military personnel. Vaccine. 2014 Jun 24;32(30):3805-9.

178. Pedersen GK, Hoschler K, Oie Solbak SM, Bredholt G, Pathirana RD, Afsar A, Breakwell L, Nøstbakken JK, Raae AJ, Brokstad KA, Sjursen H, Zambon M, Cox RJ. Serum IgG titres, but not avidity, correlates with neutralizing antibody response after H5N1 vaccination. Vaccine. 2014 Jun 17. [Epub ahead of print].

179. Peláez-Carvajal D, Cotes-Cantillo K, Paternina-Caicedo A, Gentsch J, de la Hoz-Restrepo F, Patel M. Characterization of rotavirus genotypes before and after the introduction of a monovalent rotavirus vaccine in Colombia. J Med Virol. 2014 Jun; 86(6):1083-6.

180. Perry R, Yu MC, Harwood B. Contraceptive need, counseling, and provision at  the time of human papillomavirus vaccination on a catch-up schedule. J Pediatr Adolesc Gynecol. 2014 Jun; 27(3):183-6.

181. Pesco P, Bergero P, Fabricius G, Hozbor D. Modelling the effect of changes in vaccine effectiveness and transmission contact rates on pertussis epidemiology. Epidemics. 2014 Jun; 7:13-21.

182. Phua KK, Nair SK, Leong KW. Messenger RNA (mRNA) nanoparticle tumour vaccination. Nanoscale. 2014 Jun 26; 6(14):7715-29.

183. Pichichero ME. Challenges in vaccination of neonates, infants and young children. Vaccine. 2014 Jun 30; 32(31):3886-3894.

184. PLOS ONE Staff. Correction: Towards the Conservation of Endangered Avian Species: A Recombinant West Nile Virus Vaccine Results in Increased Humoral and Cellular Immune Responses in Japanese Quail (Coturnix japonica). PLoS One. 2014 Jun 3; 9(6):e99472.

185. Pondo T, Rose CE Jr, Martin SW, Keitel WA, Keyserling HL, Babcock J, Parker  S, Jacobson RM, Poland GA, McNeil MM. Evaluation of sex, race, body mass index and pre-vaccination serum progesterone levels and post-vaccination serum anti-anthrax protective immunoglobulin G on injection site adverse events following anthrax vaccine adsorbed (AVA) in the CDC AVA human clinical trial. Vaccine. 2014 Jun 12;32(28):3548-54.

186. Porter AL, Pitterle ME, Hayney MS. Comparison of online versus classroom delivery of an immunization elective course. Am J Pharm Educ. 2014 Jun 17; 78(5):96.

187. Potter RC, DeVita SF, Vranesich PA, Boulton ML. Adolescent Immunization Coverage and Implementation of New School Requirements in Michigan, 2010. Am J Public Health. 2014 Jun 12:e1-e8. [Epub ahead of print].

188. Principi N, Esposito S. Vaccine use in primary immunodeficiency disorders. Vaccine. 2014 Jun 24; 32(30):3725-3731.

189. Pugh C, Keasey S, Korman L, Pittman PR, Ulrich RG. Human Antibody Responses  to the Polyclonal Dryvax Vaccine for Smallpox Prevention Can Be Distinguished from Responses to the Monoclonal Replacement Vaccine ACAM2000. Clin Vaccine Immunol. 2014 Jun; 21(6):877-85.

190. Puig-Barberà J, Natividad-Sancho A, Launay O, Burtseva E, Ciblak MA, Tormos  A, Buigues-Vila A, Martínez-Úbeda S, Sominina A; GIHSN Group. 2012-2013 Seasonal  Influenza Vaccine Effectiveness against Influenza Hospitalizations: Results from  the Global Influenza Hospital Surveillance Network. PLoS One. 2014 Jun 19; 9(6):e100497.

191. Quinn E, Jit M, Newall AT. Key issues and challenges in estimating the impact and cost-effectiveness of quadrivalent influenza vaccination. Expert Rev Pharmacoecon Outcomes Res. 2014 Jun; 14(3):425-35.

192. Rajabally YA. Subcutaneous immunoglobulin therapy for inflammatory neuropathy: current evidence base and future prospects. J Neurol Neurosurg Psychiatry. 2014 Jun; 85(6):631-7.

193. Ramasamy MN, Clutterbuck EA, Haworth K, Barel J, Omar O, Thompson AJ, Blanchard-Rohner G, Yu LM, Snape MD, Pollard AJ. The immunogenicity of quadrivalent meningococcal conjugate and polysaccharide vaccines: a randomized clinical trial in UK adults. Clin Vaccine Immunol. 2014 Jun 25. [Epub ahead of print].

194. Rasmussen SA, Watson AK, Kennedy ED, Broder KR, Jamieson DJ. Vaccines and pregnancy: Past, present, and future. Semin Fetal Neonatal Med. 2014 Jun; 19(3):161-169.

195. Reisinger KS, Holmes SJ, Pedotti P, Arora AK, Lattanzi M. A dose-ranging study of MF59(®)-adjuvanted and non-adjuvanted A/H1N1 pandemic influenza vaccine  in young to middle-aged and older adult populations to assess safety, immunogenicity, and antibody persistence one year after vaccination. Hum Vaccin Immunother. 2014 Jun 19; 10(8). [Epub ahead of print].

196. Ribassin-Majed L, Lounes R, Clemençon S. Deterministic modelling for transmission of Human Papillomavirus 6/11: impact of vaccination. Math Med Biol.  2014 Jun; 31(2):125-49.

197. Richardson A, Morris DE, Clarke SC. Vaccination in Southeast Asia-Reducing meningitis, sepsis and pneumonia with new and existing vaccines. Vaccine. 2014 Jun 5. [Epub ahead of print].

198. Richter D, Anca I, André FE, Bakir M, Chlibek R, Čiłman M, Mangarov A, Mészner Z, Pokorn M, Prymula R, Salman N, Simurka P, Tamm E, Tešović G, Urbančíková I, Usonis V, Wysocki J, Zavadska D. Immunization of high-risk paediatric populations: Central European Vaccination Awareness Group recommendations. Expert Rev Vaccines. 2014 Jun;13(6):801-15.

199. Riese P, Sakthivel P, Trittel S, Guzmán CA. Intranasal formulations: promising strategy to deliver vaccines. Expert Opin Drug Deliv. 2014 Jun 25:1-16. [Epub ahead of print].

200. Rinaldi S, Cagigi A, Santilli V, Zotta F, di Martino A, Castrucci MR, Donatelli I, Poggi E, Piazza A, Campana A, Guzzo I, Villani A, Rossi P, Dello Strologo L, Palma P. B-Sides Serologic Markers of Immunogenicity in Kidney Transplanted Patients: Report From 2012-2013 Flu Vaccination Experience. Transplantation. 2014 Jun 6. [Epub ahead of print].

201. Rockman S, Becher D, Dyson A, Koernig S, Morelli AB, Barnden M, Camuglia S,  Soupourmas P, Pearse M, Maraskovsky E. Role of viral RNA and lipid in the adverse events associated with the 2010 Southern Hemisphere trivalent influenza vaccine.  Vaccine. 2014 Jun 24; 32(30):3869-76.

202. Rongsen-Chandola T, Winje BA, Goyal N, Rathore SS, Mahesh M, Ranjan R, Arya  A, Rafiqi FA, Bhandari N, Strand TA. Compliance of mothers following recommendations to breastfeed or withhold breast milk during rotavirus vaccination in North India: a randomized clinical trial. Trials. 2014 Jun 28;15(1):256. [Epub ahead of print].

203. Rouleau I, De Serres G, Skowronski DM, Drolet JP, Lemire C, Toth E, Landry M. Risk factors associated with anaphylaxis and other allergic-like events following receipt of 2009 monovalent AS03 adjuvanted pandemic influenza vaccine in Quebec, Canada. Vaccine. 2014 Jun 12;32(28):3480-7.

204. Rumbo M, Hozbor D. Development of improved pertussis vaccine. Hum Vaccin Immunother. 2014 Jun 5;10(8). [Epub ahead of print].

205. Sankoh O, Welaga P, Debpuur C, Zandoh C, Gyaase S, Poma MA, Mutua MK, Hanifi SM, Martins C, Nebie E, Kagoné M, Emina JB, Aaby P. The non-specific effects of vaccines and other childhood interventions: the contribution of INDEPTH Health and Demographic Surveillance Systems. Int J Epidemiol. 2014 Jun;43(3):645-53.

206. Santiago T, Rebelo O, Negrão L, Matos A. Macrophagic myofasciitis and vaccination: Consequence or coincidence? Rheumatol Int. 2014 Jun 13. [Epub ahead of print].

207. Santos EM, Sá GR, Siqueira MM, Martins Rde M, Camacho LA, von Doellinger Vdos R, Maia Mde L. Immune response to the mumps component of the MMR vaccine in  the routine of immunization services in the Brazilian National Immunisation Program. Mem Inst Oswaldo Cruz. 2014 Jun; 109(3):335 9.

208. Savulescu C, Jiménez-Jorge S, Delgado-Sanz C, de Mateo S, Pozo F, Casas I, Larrauri A; on behalf of the Spanish Influenza Surveillance System. Higher vaccine effectiveness in seasons with predominant circulation of seasonal influenza A(H1N1) than in A(H3N2) seasons: Test-negative case-control studies using surveillance data, Spain, 2003-2011. Vaccine. 2014 Jun 23. [Epub ahead of print] .

209. Schwarz TF, Huang LM, Lin TY, Wittermann C, Panzer F, Valencia A, Suryakiran PV, Lin L, Descamps D. Long-Term Immunogenicity and Safety of the HPV-16/18 AS04-Adjuvanted Vaccine in 10-14 Year Old Girls: Open Six-Year Follow-Up of an Initial Observer-Blinded, Randomized Trial. Pediatr Infect Dis J. 2014 Jun 20. [Epub ahead of print].

210. Scobie HM, Nilles E, Kama M, Kool JL, Mintz E, Wannemuehler KA, Hyde TB, Dawainavesi A, Singh S, Korovou S, Jenkins K, Date K. Impact of a targeted typhoid vaccination campaign following cyclone tomas, republic of fiji, 2010. Am  J Trop Med Hyg. 2014 Jun 4;90(6):1031-8.

211. Scotta MC, Veras TN, Klein PC, Tronco V, Polack FP, Mattiello R, Pitrez PM,  Jones MH, Stein RT, Pinto LA. Impact of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) on childhood pneumonia hospitalizations in Brazil two years after introduction. Vaccine. 2014  Jun 20. [Epub ahead of print].

212. Shepherd SM, Shoff WH. Vaccination for the expatriate and long-term traveler. Expert Rev Vaccines. 2014 Jun;13(6):775-800.

213. Siu JY. Perceptions of and barriers to vaccinating daughters against Human Papillomavirus (HPV) among mothers in Hong Kong. BMC Womens Health. 2014 Jun 2; 14:73.

214. Slonim M, Starr M, Blashki G. Are we there yet? Travel vaccinations for Australian children. Aust Fam Physician. 2014 Jun; 43(6):378-81.

215. Song L, Liu G, Umlauf S, Liu X, Li H, Tian H, Reiserova L, Hou F, Bell R, Tussey L. A rationally designed form of the TLR5 agonist, flagellin, supports superior immunogenicity of Influenza B globular head vaccines. Vaccine. 2014 Jun  17. [Epub ahead of print].

216. Srinivasan A, Rastogi A, Ayyavoo V, Srivastava S. Nanotechnology-based approaches for the development of diagnostics, therapeutics, and vaccines. Monoclon Antib Immunodiagn Immunother. 2014 Jun;33(3):186-91.

217. Steens A, Vestrheim DF, Aaberge IS, Wiklund BS, Storsaeter J, Riise Bergsaker MA, Rønning K, Furuseth E. A review of the evidence to inform pneumococcal vaccine recommendations for risk groups aged 2 years and older. Epidemiol Infect. 2014 Jun 16:1-12. [Epub ahead of print].

218. Stoof SP, van der Klis FR, van Rooijen DM, Knol MJ, Sanders EA, Berbers GA.  Timing of an Adolescent Booster after Single Primary Meningococcal Serogroup C Conjugate Immunization at Young Age; An Intervention Study among Dutch Teenagers. PLoS One. 2014 Jun 25; 9(6):e100651.

219. Sullivan SG, Komadina N, Grant K, Jelley L, Papadakis G, Kelly H. Influenza  vaccine effectiveness during the 2012 influenza season in Victoria, Australia: influences of waning immunity and vaccine match. J Med Virol. 2014 Jun; 86(6):1017-25.

220. Taddei C, Ceccherini V, Niccolai G, Porchia BR, Boccalini S, Levi M, Tiscione E, Santini MG, Baretti S, Bonanni P, Bechini A. Attitude toward immunization and risk perception of measles, rubella, mumps, varicella, and pertussis in health care workers working in 6 hospitals of Florence, Italy 2011.  Hum Vaccin Immunother. 2014 Jun 25;10(9). [Epub ahead of print].

221. Takeuchi J, Goto M, Kawamura T, Hiraide A. Serological assessment of measles-rubella vaccination catch-up campaign among university students. Pediatr  Int. 2014 Jun;56(3):395-9.

222. Talaat KR, Luke CJ, Khurana S, Manischewitz J, King LR, McMahon BA, Karron RA, Lewis KD, Qin J, Follmann DA, Golding H, Neuzil KM, Subbarao K. A Live Attenuated Influenza A(H5N1) Vaccine Induces Long-Term Immunity in the Absence of a Primary Antibody Response. J Infect Dis. 2014 Jun 15;209(12):1860-9.

223. Tamburini BA, Burchill MA, Kedl RM. Antigen capture and archiving by lymphatic endothelial cells following vaccination or viral infection. Nat Commun. 2014 Jun 6;5:3989.

224. Tamir SO, Roth Y, Dalal I, Goldfarb A, Marom T. Acute Mastoiditis in the Pneumococcal Conjugate Vaccines Era. Clin Vaccine Immunol. 2014 Jun 11. [Epub ahead of print].

225. Tan M, Jiang X. Subviral particle as vaccine and vaccine platform. Curr Opin Virol. 2014 Jun;6C:24-33.

226. Taylor KA, Stocks N, Marshall HS. The missing link: Family physician perspectives on barriers and enablers to prescribing a new Meningococcal B vaccine and other recommended, non-government funded vaccines. Vaccine. 2014 Jun  9. [Epub ahead of print].

227. Taylor LE, Swerdfeger AL, Eslick GD. Vaccines are not associated with autism: An evidence-based meta-analysis of case-control and cohort studies. Vaccine. 2014 Jun 17;32(29):3623-9.

228. Ten Berge JC, van Daele PL, Rothova A. Rubella Virus-associated Anterior Uveitis in a Vaccinated Patient: A Case Report. Ocul Immunol Inflamm. 2014 Jun 19:1-2. [Epub ahead of print].

229. Thomas CA, Shwe T, Bixler D, Del Rosario M, Grytdal S, Wang C, Haddy LE, Bialek SR. Two-Dose Varicella Vaccine Effectiveness and Rash Severity in Outbreaks of Varicella among Public School Students. Pediatr Infect Dis J. 2014 Jun 6. [Epub ahead of print].

230. Torné AN, Dias JG, Quinten C, Hruba F, Busana MC, Lopalco PL, Gauci AJ, Pastore-Celentano L; ECDC country experts for pneumococcal disease. European enhanced surveillance of invasive pneumococcal disease in 2010: Data from 26 European countries in the post-heptavalent conjugate vaccine era. Vaccine. 2014 Jun 17; 32(29):3644-50.

231. Treanor JJ, Atmar RL, Frey SE, Gormley R, Chen WH, Ferreira J, Goodwin R, Borkowski A, Clemens R, Mendelman PM. A Novel Intramuscular Bivalent Norovirus VLP Vaccine Candidate - Reactogenicity, Safety and Immunogenicity in a phase I trial in healthy adults. J Infect Dis. 2014 Jun 20. [Epub ahead of print].

232. Trifirò G, Coloma PM, Rijnbeek PR, Romio S, Mosseveld B, Weibel D, Bonhoeffer J, Schuemie M, van der Lei J, Sturkenboom M. Combining multiple healthcare databases for postmarketing drug and vaccine safety surveillance: why  and how? J Intern Med. 2014 Jun; 275(6):551-61.

233. Troy SB, Ferreyra-Reyes L, Huang C, Sarnquist C, Canizales-Quintero S, Nelson C, Báez-Saldaña R, Holubar M, Ferreira-Guerrero E, García-García L, Maldonado YA. Community circulation patterns of oral polio vaccine serotypes 1, 2, and 3 after Mexican national immunization weeks. J Infect Dis. 2014 Jun 1;209(11):1693-9.

234. Turner N, Pierse N, Bissielo A, Huang QS, Baker MG, Widdowson MA, Kelly H; SHIVERS investigation team. The effectiveness of seasonal trivalent inactivated influenza vaccine in preventing laboratory confirmed influenza hospitalisations in Auckland, New Zealand in 2012. Vaccine. 2014 Jun 17; 32(29):3687-93.

235. Tuyishime S, Haut LH, Zhu C, Ertl HC. Enhancement of recombinant adenovirus  vaccine-induced primary but not secondary systemic and mucosal immune responses by all-trans retinoic acid. Vaccine. 2014 Jun 5;32(27):3386-92.

236. Uhlig U, Kostev K, Schuster V, Koletzko S, Uhlig HH. Impact of Rotavirus Vaccination in Germany: Rotavirus Surveillance, Hospitalization, Side Effects and Comparison of Vaccines. Pediatr Infect Dis J. 2014 Jun 6. [Epub ahead of print].

237. Ulloa-Gutierrez R, Avila-Aguero ML. Rotavirus vaccination in Central American children. Expert Rev Vaccines. 2014 Jun;13(6):687-90.

238. Van Bellinghen LA, Meier G, Van Vlaenderen I. The Potential Cost-Effectiveness of Quadrivalent versus Trivalent Influenza Vaccine in Elderly  People and Clinical Risk Groups in the UK: A Lifetime Multi Cohort Model. PLoS One. 2014 Jun 6;9(6):e98437.

239. van de Pol EM, Gisolf EH, Richter C. A Case Suspected for Yellow Fever Vaccine-Associated Viscerotropic Disease in the Netherlands. J Travel Med. 2014 Jun 11. [Epub ahead of print].

240. van der Velden MV, Geisberger A, Dvorak T, Portsmouth D, Fritz R, Crowe BA,  Herr W, Distler E, Wagner EM, Zeitlinger M, Sauermann R, Stephan C, Ehrlich HJ, Barrett PN, Aichinger G. Safety and Immunogenicity of a Vero Cell Culture-Derived Whole-Virus H5N1 Influenza Vaccine in Chronically Ill and Immunocompromised Patients. Clin Vaccine Immunol. 2014 Jun; 21(6):867-76.

241. van Sorge NM, Cole JN, Kuipers K, Henningham A, Aziz RK, Kasirer-Friede A, Lin L, Berends ET, Davies MR, Dougan G, Zhang F, Dahesh S, Shaw L, Gin J, Cunningham M, Merriman JA, Hütter J, Lepenies B, Rooijakkers SH, Malley R, Walker MJ, Shattil SJ, Schlievert PM, Choudhury B, Nizet V. The classical lancefield antigen of group a streptococcus is a virulence determinant with implications for vaccine design. Cell Host Microbe. 2014 Jun 11; 15(6):729-40.

242. Verma R, Khanna P, Chawla S. Vaccines for the elderly need to be introduced  into the immunization program in India. Hum Vaccin Immunother. 2014 Jun 23;10(8). [Epub ahead of print].

243. Verma R, Khanna P, Chawla S. Recommended vaccines for international travelers to India. Hum Vaccin Immunother. 2014 Jun 18;10(9). [Epub ahead of print].

244. Verma R, Khanna P, Chawla S. Adult immunization in India: Importance and recommendations. Hum Vaccin Immunother. 2014 Jun 18; 10(9). [Epub ahead of print].

245. Vosseler A, Wilson GA, Wilson N. Uptake of influenza vaccination and risk reduction behaviour for respiratory infections: a survey of optometrists in New Zealand. Clin Exp Optom. 2014 Jun 9. [Epub ahead of print].

246. Wagner Z, Szilagyi PG, Sood N. Comparative performance of public and private sector delivery of BCG vaccination: Evidence from Sub-Saharan Africa. Vaccine. 2014 Jun 18. [Epub ahead of print].

247. Wallis L. Not getting through: vaccination message is ineffective. Am J Nurs. 2014 Jun;114(6):16.

248. Wang D, Fu TM. Progress on human cytomegalovirus vaccines for prevention of  congenital infection and disease. Curr Opin Virol. 2014 Jun;6C:13-23.

249. Westra J, van Assen S, Wilting KR, Land J, Horst G, de Haan A, Bijl M. Rituximab impairs IgM and IgG (subclass) responses after influenza vaccination in rheumatoid arthritis patients. Clin Exp Immunol. 2014 Jun 2. [Epub ahead of print].

250. Wicker S, Maltezou HC. Vaccine-preventable diseases in Europe: where do we stand? Expert Rev Vaccines. 2014 Jun 24:1-9. [Epub ahead of print].

251. Wijesinghe PR, Abeysinghe MR, Yoksan S, Yao Y, Zhou B, Zhang L, Yaich M, Neuzil KM, Victor JC. Safety and immunogenicity of live-attenuated Japanese encephalitis SA 14-14-2 vaccine co-administered with measles vaccine in 9-month-old infants in Sri Lanka. Vaccine. 2014 Jun 18. [Epub ahead of print].

252. Wilson K, Atkinson K, Deeks S. Opportunities for utilizing new technologies  to increase vaccine confidence. Expert Rev Vaccines. 2014 Jun 14:1-9. [Epub ahead of print].

253. Wolters A, de Wert G, van Schayck OC, Horstman K. Vaccination against smoking: an annotated agenda for debate. A review of scientific journals, 2001-13. Addiction. 2014 Jun 3. [Epub ahead of print].

254. Wu UI, Wang JT, Chang SC, Chuang YC, Lin WR, Lu MC, Lu PL, Hu FC, Chuang JH, Chen YC; TIDSNet for pH1N1 vaccination. Impacts of a mass vaccination campaign against pandemic H1N1 2009 influenza in Taiwan: a time-series regression analysis. Int J Infect Dis. 2014 Jun;23:82-9.

255. Xu N, Wang J, Zhang ZF, Pang DW, Wang HZ, Zhang ZL. Anisotropic cell-to-cell spread of vaccinia virus on microgrooved substrate. Biomaterials. 2014 Jun; 35(19):5049-55.

256. Yagi M, Bang G, Tougan T, Palacpac NM, Arisue N, Aoshi T, Matsumoto Y, Ishii KJ, Egwang TG, Druilhe P, Horii T. Protective Epitopes of the Plasmodium falciparum SERA5 Malaria Vaccine Reside in Intrinsically Unstructured N-Terminal  Repetitive Sequences. PLoS One. 2014 Jun 2;9(6):e98460.

257. Yamin D, Balicer RD, Galvani AP. Cost-effectiveness of influenza vaccination in prior pneumonia patients in Israel. Vaccine. 2014 Jun 12. [Epub ahead of print]. 

258. Yang JS, Kang SS, Yun CH, Han SH. Evaluation of anticoagulants for serologic assays of cholera vaccination. Clin Vaccine Immunol. 2014 Jun;21(6):854-8.

259. Yang K, Varga SM. Mucosal vaccines against respiratory syncytial virus. Curr Opin Virol. 2014 Jun; 6C:78-84.

260. Ye Q, Li XF, Zhao H, Deng YQ, Xu YP, Wang HY, Liang GD, Qin CF. Reduction of neutralization antibody against heterologous circulating strains in adults immunized with Japanese encephalitis live vaccine. Hum Vaccin Immunother. 2014 Jun 18; 10(9). [Epub ahead of print].

261. Yurttas C, Berchtold S, Malek NP, Bitzer M, Lauer UM. Pulsed versus continuous application of the prodrug 5-fluorocytosine to enhance the oncolytic effectiveness of a measles vaccine virus armed with a suicide gene. Hum Gene Ther Clin Dev. 2014 Jun; 25(2):85-96.

262. Zadeh Hosseingholi E, Rasooli I, Mousavi Gargari SL. In Silico Analysis of Acinetobacter baumannii Phospholipase D as a Subunit Vaccine Candidate. Acta Biotheor. 2014 Jun 24. [Epub ahead of print].

263. Zhou Y, Yang K, Zhou K, Liang Y. Optimal vaccination policies for an SIR model with limited resources. Acta Biotheor. 2014 Jun;62(2):171-81.

264. Zimmerman RK, Nowalk MP, Lin CJ, Hannibal K, Moehling KK, Huang HH, Matambanadzo A, Troy J, Allred NJ, Gallik G, Reis EC. Cluster randomized trial of a toolkit and early vaccine delivery to improve childhood influenza vaccination rates in primary care. Vaccine. 2014 Jun 17; 32(29):3656-63.

[Top]